title: Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study.
authors.forename: Kimberly R
authors.initials: KR
authors.lastname: Warren
authors.forename: Robert W
authors.initials: RW
authors.lastname: Buchanan
authors.forename: Stephanie
authors.initials: S
authors.lastname: Feldman
authors.forename: Robert R
authors.initials: RR
authors.lastname: Conley
authors.forename: Jared
authors.initials: J
authors.lastname: Linthicum
authors.forename: Mary Patricia
authors.initials: MP
authors.lastname: Ball
authors.forename: Fang
authors.initials: F
authors.lastname: Liu
authors.forename: Robert P
authors.initials: RP
authors.lastname: McMahon
authors.forename: David A
authors.initials: DA
authors.lastname: Gorelick
authors.forename: Marilyn A
authors.initials: MA
authors.lastname: Huestis
authors.forename: Deanna L
authors.initials: DL
authors.lastname: Kelly
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D015992:Body Mass Index; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D063387:Cannabinoid Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D054314:Drug Inverse Agonism; D004435:Eating / Q000187:drug effects; D002149:Energy Intake / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D050177:Overweight / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D010865:Pilot Projects; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use*; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000077285:Rimonabant; D012528:Satiety Response / Q000187:drug effects*; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D015398:Signal Transduction / Q000187:drug effects; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D001067:Appetite Depressants; C571130:CNR1 protein, human; D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D000077285:Rimonabant